TY - JOUR
T1 - Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules
T2 - A prospective analysis of 1056 FNA samples
AU - Nikiforov, Yuri E.
AU - Ohori, N. Paul
AU - Hodak, Steven P.
AU - Carty, Sally E.
AU - LeBeau, Shane O.
AU - Ferris, Robert L.
AU - Yip, Linwah
AU - Seethala, Raja R.
AU - Tublin, Mitchell E.
AU - Stang, Michael T.
AU - Coyne, Christopher
AU - Johnson, Jonas T.
AU - Stewart, Andrew F.
AU - Nikiforova, Marina N.
PY - 2011/11
Y1 - 2011/11
N2 - Context: Thyroid nodules are common in adults, but only a small fraction of them is malignant. Fine-needle aspiration (FNA) cytology provides a definitive diagnosis of benign or malignant disease in many cases, whereas about25%of nodules are indeterminate, hindering most appropriate management. Objective: The objective of the investigation was to study the clinical utility of molecular testing of thyroid FNA samples with indeterminate cytology. Design: Residual material from 1056 consecutive thyroid FNA samples with indeterminate cytology was used for prospective molecular analysis that included the assessment of cell adequacy by a newly developed PCR assay and testing for a panel of mutations consisted of BRAF V600E, NRAS codon 61, HRAS codon 61, and KRAS codons 12/13 point mutations and RET/PTC1, RET/PTC3, and PAX8/PPARγ rearrangements. Results: The collected material was adequate for molecular analysis in 967 samples (92%), which yielded 87 mutations including 19 BRAF, 62 RAS, 1 RET/PTC, and five PAX8/PPARγ. Four hundred seventy-nine patients who contributed 513 samples underwent surgery. In specific categories of indeterminate cytology, i.e. atypia of undetermined significance/follicular lesion of undetermined significance, follicular neoplasm/suspicious for a follicular neoplasm, and suspicious for malignant cells, the detection of any mutation conferred the risk of histologic malignancy of 88, 87, and 95%, respectively. The risk of cancer in mutation-negative nodules was 6, 14, and 28%, respectively. Of 6% of cancers in mutation-negative nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytology, only 2.3% were invasive and 0.5% had extrathyroidal extension. Conclusion: Molecular analysis for a panel of mutations has significant diagnostic value for all categories of indeterminate cytology and can be helpful for more effective clinical management of these patients.
AB - Context: Thyroid nodules are common in adults, but only a small fraction of them is malignant. Fine-needle aspiration (FNA) cytology provides a definitive diagnosis of benign or malignant disease in many cases, whereas about25%of nodules are indeterminate, hindering most appropriate management. Objective: The objective of the investigation was to study the clinical utility of molecular testing of thyroid FNA samples with indeterminate cytology. Design: Residual material from 1056 consecutive thyroid FNA samples with indeterminate cytology was used for prospective molecular analysis that included the assessment of cell adequacy by a newly developed PCR assay and testing for a panel of mutations consisted of BRAF V600E, NRAS codon 61, HRAS codon 61, and KRAS codons 12/13 point mutations and RET/PTC1, RET/PTC3, and PAX8/PPARγ rearrangements. Results: The collected material was adequate for molecular analysis in 967 samples (92%), which yielded 87 mutations including 19 BRAF, 62 RAS, 1 RET/PTC, and five PAX8/PPARγ. Four hundred seventy-nine patients who contributed 513 samples underwent surgery. In specific categories of indeterminate cytology, i.e. atypia of undetermined significance/follicular lesion of undetermined significance, follicular neoplasm/suspicious for a follicular neoplasm, and suspicious for malignant cells, the detection of any mutation conferred the risk of histologic malignancy of 88, 87, and 95%, respectively. The risk of cancer in mutation-negative nodules was 6, 14, and 28%, respectively. Of 6% of cancers in mutation-negative nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytology, only 2.3% were invasive and 0.5% had extrathyroidal extension. Conclusion: Molecular analysis for a panel of mutations has significant diagnostic value for all categories of indeterminate cytology and can be helpful for more effective clinical management of these patients.
UR - http://www.scopus.com/inward/record.url?scp=80655147350&partnerID=8YFLogxK
U2 - 10.1210/jc.2011-1469
DO - 10.1210/jc.2011-1469
M3 - Article
C2 - 21880806
AN - SCOPUS:80655147350
SN - 0021-972X
VL - 96
SP - 3390
EP - 3397
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 11
ER -